Central pontine myelinolysis epidemiology and demographics
|
Central pontine myelinolysis Microchapters |
|
Differentiating Central pontine myelinolysis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Central pontine myelinolysis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Central pontine myelinolysis epidemiology and demographics |
|
FDA on Central pontine myelinolysis epidemiology and demographics |
|
CDC on Central pontine myelinolysis epidemiology and demographics |
|
Central pontine myelinolysis epidemiology and demographics in the news |
|
Blogs on Central pontine myelinolysis epidemiology and demographics |
|
Risk calculators and risk factors for Central pontine myelinolysis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
The prevalence of central pontine myelinolysis is approximately 250–500 per 100,000 in the general population. Among hospitalized patients in the ICU the incidence of central pontine myelinolysis is approximately 2500 per 100,000 patients. Among patients undergoing liver transplantation the incidence of central pontine myelinolysis is approximately 10,000 per 100,000 patients. The case-mortality rate of central pontine myelinolysis is approximately 12%. Patients of all age groups may develop central pontine myelinolysis but the incidence of central pontine myelinolysis increases with age. There is no racial predilection to central pontine myelinolysis. Central pontine myelinolysis affects men and women equally. There is no regional predilection to central pontine myelinolysis.
Epidemiology and Demographics
Incidence and prevalence
- The prevalence of central pontine myelinolysis is approximately 250–500 per 100,000 in the general population.[1]
- Among hospitalized patients in the ICU the incidence of central pontine myelinolysis is approximately 2500 per 100,000 patients.[2][1]
- Among patients undergoing liver transplantation the incidence of central pontine myelinolysis is approximately 10,000 per 100,000 patients.[2][3][1]
Mortality rate
- The case-mortality rate of central pontine myelinolysis is approximately 12%.[1]
Age
- Patients of all age groups may develop central pontine myelinolysis but the incidence of central pontine myelinolysis increases with age.
Race
- There is no racial predilection to central pontine myelinolysis.
Gender
- Central pontine myelinolysis affects men and women equally.[4]
Region
- There is no regional predilection to central pontine myelinolysis.
References
- ↑ 1.0 1.1 1.2 1.3 Rao PB, Azim A, Singh N, Baronia AK, Kumar A, Poddar B (2015). "Osmotic demyelination syndrome in Intensive Care Unit". Indian J Crit Care Med. 19 (3): 166–9. doi:10.4103/0972-5229.152760. PMC 4366916. PMID 25810613.
- ↑ 2.0 2.1 Menger H, Jörg J (1999). "Outcome of central pontine and extrapontine myelinolysis (n = 44)". J Neurol. 246 (8): 700–5. PMID 10460448.
- ↑ Lampl C, Yazdi K (2002). "Central pontine myelinolysis". Eur Neurol. 47 (1): 3–10. doi:10.1159/000047939. PMID 11803185.
- ↑ Bansal LR, Zinkus T (2019). "Osmotic Demyelination Syndrome in Children". Pediatr Neurol. 97: 12–17. doi:10.1016/j.pediatrneurol.2019.03.018. PMID 31128892.